Evidence map›Paper›PMID 22833143›Full record

ArticleArthritis and rheumatism2012

Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus.

Indra Adrianto, Shaofeng Wang, Graham B Wiley, Christopher J Lessard, Jennifer A Kelly, Adam J Adler, Stuart B Glenn, Adrienne H Williams, Julie T Ziegler, Mary E Comeau and 40 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 78 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Repressive Control of Keratinocyte Cytoplasmic Inflammatory Signaling.International journal of molecular sciences · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. LUBAC-mediated linear ubiquitination: a crucial regulator of immune signaling.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2021
    Review
  11. Lupus science & medicine · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Journal of clinical medicine · 2019
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors at 20 institutions in 6 countries.

Indra AdriantoOklahoma Medical Research Foundation, Oklahoma City, USA.
Shaofeng Wang
Graham B Wiley
Christopher J Lessard
Jennifer A Kelly
Adam J Adler
Stuart B Glenn
Adrienne H Williams
Julie T Ziegler
Mary E Comeau
Miranda C Marion
Benjamin E Wakeland
Chaoying Liang
Kenneth M Kaufman
Joel M Guthridge
Marta E Alarcón-Riquelme
BIOLUPUS and GENLES Networks
Graciela S Alarcón
Juan-Manuel Anaya
Sang-Cheol Bae
Jae-Hoon Kim
Young Bin Joo
Susan A Boackle
Elizabeth E Brown
Michelle A Petri
Rosalind Ramsey-Goldman
John D Reveille
Luis M Vilá
Lindsey A Criswell
Jeffrey C Edberg
Barry I Freedman
Gary S Gilkeson
Chaim O Jacob
Judith A James
Diane L Kamen
Robert P Kimberly
Javier Martín
Joan T Merrill
Timothy B Niewold
Bernardo A Pons-Estel
R Hal Scofield
Anne M Stevens
Betty P Tsao
Timothy J Vyse
Carl D Langefeld
John B Harley
Edward K Wakeland
Kathy L Moser
Courtney G Montgomery
Patrick M Gaffney
Oklahoma Medical Research Foundation · USWake Forest University · USUniversity of Alabama at Birmingham · USUniversity of Oklahoma · USHanyang University · KRThe University of Texas at Austin · USCincinnati Children's Hospital Medical Center · USMedical University of South Carolina · USJohns Hopkins University · USKing's College London · GBNorthwestern University · USThe University of Texas Health Science Center at Houston · USUniversidad de Granada · ESUniversidad del Rosario · COUniversity of California, Los Angeles · USUniversity of California, San Francisco · USUniversity of Chicago · USUniversity of Colorado Boulder · USUniversity of Puerto Rico, Medical Sciences Campus · PRUniversity of Southern California · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Institute for Clinical and Translational Research (UL1)UL1RR025005 · NCRR · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2007 to 2011
$75.8M
INSTITUTE FOR TRANSLATIONAL HEALTH SCIENCE (UL1): BPCAUL1RR025014 · NCRR · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2007 to 2011
$51.5M
U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR024148 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2010
$27.9M
ZD1839 FOR MALIGNANT ASTROCYTOMA OR GLIOBLASTOMA AND MENINGIOMAM01RR000079 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$26.0M
TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
MULTIDISCIPLINARY CLINICAL AND TRANSLATIONAL SCIENCE (MCTS) PROGRAM (UL1)UL1RR025741 · NCRR · NORTHWESTERN UNIVERSITY AT CHICAGO · PI GREENLAND, PHILIP · 2008 to 2011
$24.7M
UAB CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) UL1: BPCAUL1RR025777 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUAY-WOODFORD, LISA MARIE · 2008 to 2011
$22.3M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KAUFMAN, KENNETH M · 2004 to 2011
$21.0M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
Arthritis Research UKNCATS NIH HHS UL1 TR000150NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000371NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA141700NCI NIH HHS R01-CA-141700NCRR NIH HHS 1U54-RR-23417-01NCRR NIH HHS 5UL1-RR-025777NCRR NIH HHS M01 RR000079NCRR NIH HHS M01-RR-00079NCRR NIH HHS P20 RR020143NCRR NIH HHS P20-RR-020143NCRR NIH HHS P30 RR031152NCRR NIH HHS P30-RR-031152NCRR NIH HHS UL1 RR024148NCRR NIH HHS UL1 RR024999NCRR NIH HHS UL1-RR-024999NCRR NIH HHS UL1 RR025005NCRR NIH HHS UL1-RR-025005NCRR NIH HHS UL-1RR025005NCRR NIH HHS UL1 RR025014NCRR NIH HHS UL1 RR025741NCRR NIH HHS UL1-RR-025741NCRR NIH HHS UL1 RR025777NCRR NIH HHS UL1 RR029882NCRR NIH HHS UL1-RR-029882NCRR NIH HHS ULI-RR-025014-02NIAID NIH HHS AI-071651NIAID NIH HHS K08 AI083790NIAID NIH HHS K08-AI-083790NIAID NIH HHS K24 AI078004NIAID NIH HHS L30 AI071651NIAID NIH HHS N01-AI-50026NIAID NIH HHS P01 AI083194NIAID NIH HHS P01-AI-083194NIAID NIH HHS R01 AI063274NIAID NIH HHS R01-AI-063274NIAID NIH HHS R01 AI070983NIAID NIH HHS R01-AI-070983NIAID NIH HHS R21 AI070304NIAID NIH HHS R21-AI-070304NIAID NIH HHS U19 AI082714NIAID NIH HHS U19-AI-082714NIAMS NIH HHS K24 AR002138NIAMS NIH HHS K24-AR-002138NIAMS NIH HHS N01-AR-62277NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR-49084NIAMS NIH HHS P30 AR048311NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P30-AR-053483NIAMS NIH HHS P30-AR-48311NIAMS NIH HHS P60 2-AR-30692NIAMS NIH HHS P60 AR030692NIAMS NIH HHS P60 AR049459NIAMS NIH HHS P60-AR-049459NIAMS NIH HHS P60 AR053308NIAMS NIH HHS P60-AR-053308NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R01 AR033062NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01-AR-042460NIAMS NIH HHS R01 AR043274NIAMS NIH HHS R01-AR-043274NIAMS NIH HHS R01 AR043727NIAMS NIH HHS R01-AR-043727NIAMS NIH HHS R01 AR043814NIAMS NIH HHS R01 AR051545NIAMS NIH HHS R01-AR-051545-01A2NIAMS NIH HHS R01 AR056360NIAMS NIH HHS R01-AR-056360NIAMS NIH HHS R01 AR057172NIAMS NIH HHS R01 AR063124NIAMS NIH HHS R01-AR-33062NIAMS NIH HHS R01-AR-43727NIAMS NIH HHS R01-AR-43814NIAMS NIH HHS RC1 AR058554NIAMS NIH HHS RC1-AR-058554NIAMS NIH HHS RC1 AR058621NIAMS NIH HHS RC1-AR-058621NIAMS NIH HHS RC2 AR058959NIAMS NIH HHS RC2-AR-058959NIDCR NIH HHS R01 DE018209NIDCR NIH HHS R01-DE-018209NIGMS NIH HHS P20 GM103456NIGMS NIH HHS P20-GM-103456PHS HHS R37-24717Wellcome Trust
6 · The paper itself

Abstract

objectiveSystemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody production and altered type I interferon expression. Genetic surveys and genome-wide association studies have identified >30 SLE susceptibility genes. One of these genes, TNIP1, encodes the ABIN1 protein. ABIN1 functions in the immune system by restricting NF-κB signaling. The present study was undertaken to investigate the genetic factors that influence association with SLE in genes that regulate the NF-κB pathway.

methodsWe analyzed a dense set of genetic markers spanning TNIP1 and TAX1BP1, as well as the TNIP1 homolog TNIP2, in case-control populations of diverse ethnic origins. TNIP1, TNIP2, and TAX1BP1 were fine-mapped in a total of 8,372 SLE cases and 7,492 healthy controls from European-ancestry, African American, Hispanic, East Asian, and African American Gullah populations. Levels of TNIP1 messenger RNA (mRNA) and ABIN1 protein in Epstein-Barr virus-transformed human B cell lines were analyzed by quantitative reverse transcription-polymerase chain reaction and Western blotting, respectively.

resultsWe found significant associations between SLE and genetic variants within TNIP1, but not in TNIP2 or TAX1BP1. After resequencing and imputation, we identified 2 independent risk haplotypes within TNIP1 in individuals of European ancestry that were also present in African American and Hispanic populations. Levels of TNIP1 mRNA and ABIN1 protein were reduced among subjects with these haplotypes, suggesting that they harbor hypomorphic functional variants that influence susceptibility to SLE by restricting ABIN1 expression.

conclusionOur results confirm the association signals between SLE and TNIP1 variants in multiple populations and provide new insight into the mechanism by which TNIP1 variants may contribute to SLE pathogenesis.

Indexed as

Adaptor Proteins, Signal TransducingAsianBlack or African AmericanB-LymphocytesCell Line, TransformedDNA-Binding ProteinsFemaleGenetic MarkersGenetic Predisposition to DiseaseHaplotypesHispanic or LatinoHumansIntracellular Signaling Peptides and ProteinsLupus Erythematosus, SystemicMaleNeoplasm ProteinsAdaptor Proteins, Signal TransducingDNA-Binding ProteinsGenetic MarkersIntracellular Signaling Peptides and ProteinsNeoplasm ProteinsTAX1BP1 protein, humanTNIP1 protein, humanTNIP2 protein, human

Identifiers

PMID22833143
PMCPMC3485412
OpenAlexW1980009864

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.